Ceribell, Inc. (CBLL)
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Sector: Electromedical & Electrotherapeutic Apparatus
Industry: Medical - Devices
CeriBell, Inc.
NASDAQ:CBLLHealthcare · Medical - Devices
-4.46%$26.58
AH$26.58+0.00%vs close
Mkt Cap$1.02B
Float23.08M
O/S38.38M
Vol
$ Vol
RVOL
Inst Own80.1%
SI9.3%
Earnings
Dilution
Financials Summary
Revenue$89.06M
Net Income-$53.41M
Total Assets$195.8M
Free Cash Flow-$41.58M
Debt & Equity
Debt 13%
Equity 87%
Total Debt$22.28M
Total Equity$155.34M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in CBLL's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$195.8M
Liabilities$40.47M
Accounts Receivable$15.05M
Accounts Payable$2.84M
Inventory$7.29M
PP&E (Net)$4.33M
Goodwill$0
Intangible Assets$805K
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Currency | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Revenue | $89.06M | $65.44M | $45.23M | $25.92M |
| YoY Growth | 36.1% | 44.7% | 74.5% | - |
| Cost of Revenue | $10.79M | $8.69M | $7.06M | $4.43M |
| Gross Profit | $78.27M | $56.75M | $38.16M | $21.49M |
| Gross Margin | 87.9% | 86.7% | 84.4% | 82.9% |
| Research and Development | $19.14M | $13.56M | $8.99M | $7.24M |
| Selling, General, and Administrative | $117.53M | $82.9M | $59.21M | $50.27M |
| Other | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $136.68M | $96.46M | $68.2M | $57.51M |
| Operating Income (EBIT) | -$58.4M | -$39.71M | -$30.04M | -$36.02M |
| Operating Margin | -65.6% | -60.7% | -66.4% | -139.0% |
| Interest Expense | $1.89M | $1.99M | $2.1M | $1.6M |
| Interest Income | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $4.99M | -$746K | $588K | -$1.14M |
| Income Before Tax (EBT) | -$53.41M | -$40.45M | -$29.45M | -$37.16M |
| Income Tax Expense | $0 | $0 | $11K | $2K |
| Net Income | -$53.41M | -$40.45M | -$29.46M | -$37.16M |
| Net Income Margin | -60.0% | -61.8% | -65.1% | -143.4% |
| Supplementary Data | ||||
| EPS | -1.46 | -1.13 | -1.26 | -1.59 |
| Diluted EPS | -1.46 | -1.13 | -1.26 | -1.59 |
| Weighted Average OS | 36.54M | 35.85M | 23.32M | 23.32M |
| EBITDA | -$50.18M | -$37.32M | -$26.51M | -$35.06M |
| EBITDA Margin | -56.3% | -57.0% | -58.6% | -135.3% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Currency | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Assets | ||||
| Current Assets | ||||
| Cash and Cash Equivalents | $40.48M | $194.37M | $34.49M | $68.23M |
| Short-Term Investments | $118.78M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $159.26M | $194.37M | $34.49M | $68.23M |
| Accounts Receivable | $15.05M | $10.88M | $7.96M | $5.29M |
| Inventory | $7.29M | $6.94M | $5.87M | $4.08M |
| Other Current Assets | $5.12M | $5.09M | $3.65M | $2.19M |
| Total Current Assets | $186.72M | $217.27M | $51.96M | $79.8M |
| Long-Term Assets | ||||
| Property, Plant & Equipment Net | $4.33M | $4.45M | $3.74M | $3.87M |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangible Assets | $805K | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $3.95M | $3.69M | $3.22M | $2.79M |
| Total Long-Term Assets | $9.09M | $8.14M | $6.96M | $6.66M |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $195.8M | $225.41M | $58.92M | $86.46M |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | $2.84M | $1.14M | $732K | $423K |
| Short-Term Debt | $0 | $0 | $11.83M | $2.5M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $101K | $97K | $206K | $343K |
| Other Current Liabilities | $4.01M | $5M | $3.73M | $2.51M |
| Total Current Liabilities | $19.19M | $12.99M | $21.6M | $9.86M |
| Long-Term Liabilities | ||||
| Long-Term Debt | $19.81M | $19.56M | $0 | $12.72M |
| Long-Term Unearned Revenue | $0 | $30K | $44K | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $106K | $356K | $147.85M | $147.9M |
| Total Long-Term Liabilities | $21.17M | $21.26M | $149.57M | $162.99M |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Total Liabilities | $40.47M | $34.25M | $171.17M | $172.86M |
| Stockholders' Equity | ||||
| Preferred Stock | $0 | $0 | $0 | $0 |
| Common Stock | $38K | $36K | $5K | $5K |
| Retained Earnings | -$220.36M | -$166.94M | -$126.49M | -$97.03M |
| Comprehensive Income & Other | $159K | $0 | $0 | $0 |
| Other Stockholders' Equity | $375.65M | $358.07M | $14.23M | $10.62M |
| Total Equity | $155.34M | $191.16M | -$112.25M | -$86.4M |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $195.8M | $225.41M | $58.92M | $86.46M |
| Supplementary Data | ||||
| Total Debt | $22.28M | $21.96M | $14.2M | $18.22M |
| Net Debt | -$18.2M | -$172.41M | -$20.29M | -$50.02M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Currency | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Operating Activities | ||||
| Net Income | -$53.41M | -$40.45M | -$29.46M | -$37.16M |
| Depreciation & Amortization | $1.34M | $1.14M | $847K | $497K |
| Deferred Income Tax | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $12.22M | $5.41M | $2.68M | $7.93M |
| Changes in Working Capital: | ||||
| Accounts Receivable | -$4.17M | -$3.51M | -$3.43M | -$3.96M |
| Inventory | -$351K | -$1.07M | -$1.79M | -$1.9M |
| Accounts Payable | $1.75M | $250K | $309K | $124K |
| Other Working Capital | $3.41M | $1.16M | $1.22M | $1.85M |
| Total Working Capital Change | $633K | -$3.17M | -$3.7M | -$3.88M |
| Other Non-Cash Items | -$1.59M | $2.03M | $477K | $621K |
| Net Cash from Operating | -$40.81M | -$35.04M | -$29.16M | -$32M |
| Investing Activities | ||||
| Capital Expenditures | -$767K | -$1.34M | -$983K | -$516K |
| Acquisitions | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$210.81M | $0 | $0 | $0 |
| Sales of Investments | $94.2M | $0 | $0 | $0 |
| Other Investing Activities | -$755K | -$258K | -$780K | -$883K |
| Net Cash from Investing | -$118.14M | -$1.6M | -$1.76M | -$1.4M |
| Financing Activities | ||||
| Debt Repaid | - | -$7.91M | $3.75M | $39K |
| Common Stock Issuance | $5.44M | $188.91M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$386K | -$304K | $932K | $154K |
| Net Cash from Financing | $5.05M | $196.52M | -$2.82M | $49.8M |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$153.89M | $159.88M | -$33.74M | $16.4M |
| Supplementary Data | ||||
| Operating Cash Flow | -$40.81M | -$35.04M | -$29.16M | -$32M |
| Capital Expenditure | -$767K | -$1.34M | -$983K | -$516K |
| Free Cash Flow | -$41.58M | -$36.38M | -$30.14M | -$32.52M |
| Cash at Beginning | $194.37M | $34.49M | $68.23M | $51.83M |
| Cash at End | $40.48M | $194.37M | $34.49M | $68.23M |